BIAF 0.97 (-10.19%)
US09076W1099• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. BIAF

BioAffinity Technologies (BIAF) Competitor Comparison

We are evaluating the key criteria listed to compare BioAffinity Technologies (BIAF) against its competitors in the Diagnostics & Research industry.

Market Capitalization

53 / 58

Gross Profits

0 / 52

Total Revenue

55 / 57

EBITDA

30 / 56

Free Cashflow

34 / 56

Quick Ratio

22 / 57

Earnings per Share

35 / 56

Dividend yield

0 / 9

Total Cash

54 / 57

Performance 3 years

48 / 58

Performance 5 years

52 / 58

Performance 10 years

49 / 58

Linearity 3 years

50 / 58

Linearity 5 years

49 / 58

Linearity 10 years

31 / 58

Total Rank

14 / 58

Dividend Rank

41 / 58

Valuation Rank

35 / 58

Piotroski Rank

14 / 58

Muliplier Rank

9 / 58

Linearity 3 years - BIAF ranking 50 / 58

These are the competitors of BioAffinity Technologies in the industry Diagnostics & Research ranked by linearity 3 years
1. Quest Diagnostics DGX
104.68
2. Anixa Biosciences ANIX
104.44
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Laboratory Corp of America Holdings LH
29.21
5. Agilent Technologies A
18.15
6. PerkinElmer PKI
16.14
7. Waters WAT
13.71
8. Thermo Fisher Scientific TMO
10.86
9. Syneos Health SYNH
10.68
10. Danaher DHR
10.33
11. Bioventus BVS
9.9
12. Icon ICLR
9.49
13. Qiagen QGEN
9.33
14. Mettler-Toledo MTD
9.08
15. Exact Sciences EXAS
8.39
16. Heska HSKA
7.67
17. IQVIA Holdings IQV
7.55
18. Olink Holding OLK
6.67
19. IDEXX Laboratories IDXX
6.5
20. Myriad Genetics MYGN
6.16
21. Sotera Health SHC
4.64
22. DexCom DXCM
4.57
23. Global Cord Blood CO
4.22
24. National Research NRC
4.19
25. Charles River Laboratories CRL
3.76
26. Sera Prognostics SERA
3.64
27. Twist Bioscience TWST
3.19
28. CareDx CDNA
3.01
29. NeoGenomics NEO
2.98
30. Psychemedics PMD
2.79
31. Illumina ILMN
2.69
32. Enzo Biochem ENZ
2.57
33. MDxHealth MDXH
2.52
34. Medpace Holdings MEDP
2.5
35. MaxCyte MXCT
2.47
36. Neogen NEOG
2.46
37. Guardant Health GH
2.34
38. Exagen XGN
2.17
39. Fulgent Genetics FLGT
2.17
40. Biodesix BDSX
2.03
41. Trinity Biotech TRIB
2.02
42. Neuronetics STIM
1.98
43. Interpace Biosciences IDXG
1.86
44. Precipio PRPO
1.86
45. Personalis PSNL
1.81
46. Pacific Biosciences of California PACB
1.8
47. DarioHealth DRIO
1.79
48. Organovo Holdings ONVO
1.79
49. Co-Diagnostics CODX
1.7
50. bioAffinity Technologies BIAF
1.66
51. Prenetics Global PRE
1.61
52. SeqLL SQL
1.48
53. Inotiv NOTV
1.45
54. Aspira Womens Health AWH
1.38
55. Lantheus Holdings LNTH
1.3
56. Meridian Bioscience VIVO
0.73
57. Natera NTRA
0.68
58. RadNet RDNT
0.37
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.